HKE Holdings Limited is a Singaporebased company specializing in healthcarerelated design and build services, focusing on medical, pharmaceutical, and biotechnology facilities、Here’s a concise overview:

Key Details:
Listing: Mainboard of the Singapore Exchange (SGX) under stock code 5VF.
Core Business:
Design & Build: Turnkey solutions for labs, cleanrooms, and healthcare facilities、
Engineering Services: HVAC, mechanical, electrical, and process systems、
Maintenance & Retrofitting: Upgrading existing medical/pharma infrastructure、
Clients: Hospitals, research institutes, pharmaceutical companies, and government agencies.

Recent Developments (2023–2024):
Expanded projects in Singapore and Southeast Asia, leveraging postpandemic healthcare investment.
Ventured into modular cleanroom solutions for biotech startups.
Financial performance impacted by supply chain costs but maintained steady order books.

Financials (Check Latest Reports):
Revenue streams: Construction (primary), maintenance contracts.
Risks: Project delays, material cost fluctuations.

Investor Considerations:
Strengths: Niche expertise in highdemand healthcare infrastructure、
Challenges: Competition, reliance on Singapore market、
Monitor: SGX announcements for quarterly results/new contracts.

For realtime data, visit [SGX](https://www.sgx.com) or the company’s website、Let me know if you need deeper analysis!